HKU scientists invent universal antibody drug for HIV-1 prevention, immget bracelets madeunotherapyAre Music Festivals For Me? Sun-kissed beaches, pleasant weather, friendly people, interesting events, amusement parks, museums, greenery and picturesque views! Isn"t that enough to beckon you to San Diego. A large number of tourists come to San Diego in the month of October. Reasons being pleasant weather, hosts of fascinating events and plenty of fun activities and great places to relax! During Big Boi"s spring 2013 North American tour the rapper will perform 43 concerts over a two month time span. He will not only be performing headlining shows but will also make appearances at the Beale Street festival wristbands, Summer Camp festival wristbands, and at the NXNE Festival.
HONG KONG - A research team led by scientists of the University of Hong Kong (HKU) announced Thursday the invention of a universal antibody drug against HIV/AIDS that can "kill two birds with one stone."
By engineering a tandem bi-specific broadly neutralizing antibody (bNAb), the team found that this novel antibody drug is universally effective not only against all genetically divergent global HIV-1 strains tested, but also promoting the elimination of latently infected cells in a humanized mouse model, the team announced at a press conference.
The single gene-encoded tandem bNAb titled "BiIA-SG" strategically ambushes invading HIV-1 particles to protect CD4 positive T cells by attaching to host protein CD4. BiIA-SG not only displays a potent activity against all three panels of 124 genetically divergent global HIV-1 strains tested, but also prevents diverse live viral challenges completely in humanized mice.
Moreover, gene transfer of BiIA-SG achieves pro-longed drug availability in vivo, leading to a promising efficacy of eliminating HIV-1 infected cells in humanized mice.
With significantly improved breadth and potency, BiIA-SG will hopefully be the first "made in Hong Kong" anti-HIV-1 antibody drug for clinical development, the team said.
The research team was led by scientists at AIDS Institute and Department of Microbiology of HKU"s Li Ka Shing Faculty of Medicine. The new findings were published in the April issue of Journal of Clinical Investigation, one of the world"s leading biomedical journals.